Type 2 Diabetes Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People with type 2 diabetes who are receiving care at the Akdeniz University Hospital Endocrinology and Metabolic Diseases Outpatient Clinic.
- People who have one or more diabetic foot risk factors, classified as category 2 or 3 under the IWGDF (International Working Group on the Diabetic Foot) Risk Classification System (confirm with trial site).
- People who have been diagnosed with type 2 diabetes for at least six months.
- People aged between 30 and 65 years.
- People who are able to read and write.
- People who have no physical or mental difficulties that would prevent them from answering study questions.
- People who have no barriers to communication.
- People who are able to understand and describe their own diagnosis.
- People whose HbA1c (a blood sugar level measurement) is 7.5% or higher.
- People who have internet access at home and own a device such as a computer, tablet, or smartphone, and are able to use it.
- People who are willing to give their informed consent to take part in the study.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have had a heart attack, stroke, heart failure, or chest pain (angina) in the past year.
- People who have been diagnosed with type 1 diabetes or gestational diabetes (diabetes during pregnancy).
- People who currently have an active diabetic foot ulcer (an open wound on the foot related to diabetes).
- People who have been diagnosed with dementia or cognitive difficulties.
- People who have been diagnosed with glaucoma, cataracts, or damage to the eyes related to diabetes (retinopathy).
- People who have been diagnosed with a terminal illness.
- People who are unable to provide accurate information or participate fully in the study.
- People who choose to withdraw from the study during the follow-up period.
- People who are unable to complete at least two-thirds of the follow-up period for any reason.
- People who undergo weight-loss (bariatric) surgery during the study.
- People who do not take their prescribed medications as directed during the study.
- People whose general health, by their own account, becomes unsuitable for continuing the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
If this is close to home
This page includes language about advanced illness, prognosis, or palliative care, because that is how the trial's eligibility criteria are written. Seeing it set out plainly can land hard, whether it is about you or about someone you are caring for. You do not have to be at a crisis point to talk to someone.
- Griefline — grief and loss counselling, 9am to 6pm weekdays and midday to 6pm weekends (AEST/AEDT): 1300 845 745
- Carer Gateway — practical and emotional support if you are caring for someone, 8am to 5pm weekdays: 1800 422 737
- Canteen — for 12 to 25 year olds affected by cancer, their own or a family member's: 1800 945 215
- Palliative Care Australia — directory of palliative care services near you: palliativecare.org.au
- Lifeline — 24/7, for any kind of distress, at any hour the services above are closed: 13 11 14
Palliative care is not the same as giving up on treatment, and it is not only for the last weeks of life. It is symptom and comfort care that can run alongside active treatment, including a clinical trial.
Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of support and crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention.
Voxsanity is not a counselling or medical service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.
Contact this trial
Principal Investigator: Sultan Akcimen Patat, Akdeniz University
Phone: +905055617687
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Diabetes Foot Knowledge Scale; Diabetic Foot Behaviour Scale; Nottingham Functional Foot Care Diagnosis Form; Diabetic Foot Self-Management Scale; Diabetic Foot Development Monitoring Form; Glycaemic Control Form; Target Tracking Cards
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.